TR201901717T4 - CMAP27 ye dayalı antimikrobiyal peptidler. - Google Patents
CMAP27 ye dayalı antimikrobiyal peptidler. Download PDFInfo
- Publication number
- TR201901717T4 TR201901717T4 TR2019/01717T TR201901717T TR201901717T4 TR 201901717 T4 TR201901717 T4 TR 201901717T4 TR 2019/01717 T TR2019/01717 T TR 2019/01717T TR 201901717 T TR201901717 T TR 201901717T TR 201901717 T4 TR201901717 T4 TR 201901717T4
- Authority
- TR
- Turkey
- Prior art keywords
- cmap27
- derivatives
- antimicrobial peptides
- peptides based
- adjuvants
- Prior art date
Links
- 101100222215 Gallus gallus CATHL2 gene Proteins 0.000 title abstract 4
- 102000044503 Antimicrobial Peptides Human genes 0.000 title 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000002949 hemolytic effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Buluş, doğal suş CMAP27 peptidi ile karşılaştırıldığında iyi bir antimikrobiyel aktivite ve düşük bir hemolitik aktiviteye sahip olan CMAP27 deriveleri ile ilgilidir. Bu deriveler antibiyotik terapiye yönelik veya bir bakterisidal bileşimde kullanılabilir. Buluşta ayrıca CMAP27 ve/veya bunun derivelerinin adjuvan olarak kullanımı kapsanır.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09152810 | 2009-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201901717T4 true TR201901717T4 (tr) | 2019-03-21 |
Family
ID=40671145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/01717T TR201901717T4 (tr) | 2009-02-13 | 2010-02-12 | CMAP27 ye dayalı antimikrobiyal peptidler. |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9006174B2 (tr) |
| EP (2) | EP3150627B1 (tr) |
| DK (2) | DK3150627T3 (tr) |
| ES (2) | ES2613266T3 (tr) |
| HR (1) | HRP20190262T1 (tr) |
| HU (2) | HUE031681T2 (tr) |
| PL (2) | PL2396345T3 (tr) |
| PT (2) | PT3150627T (tr) |
| SI (1) | SI3150627T1 (tr) |
| TR (1) | TR201901717T4 (tr) |
| WO (1) | WO2010093245A1 (tr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6676544B2 (ja) * | 2014-05-09 | 2020-04-08 | ユニベルシテイト、ユトレヒト、ホールディング ベスローテン、フェンノートシャップＵｎｉｖｅｒｓｉｔｅｉｔ Ｕｔｒｅｃｈｔ Ｈｏｌｄｉｎｇ Ｂ．Ｖ． | 新しいｃａｔｈ２誘導体。 |
| CN107043428A (zh) * | 2017-05-02 | 2017-08-15 | 东北农业大学 | 一种α螺旋结构的抗炎杂合抗菌肽及其制备方法和应用 |
| CN110128544B (zh) * | 2019-04-03 | 2020-12-01 | 中国农业大学 | 一种具有免疫调节和抗炎功能的杂合肽及其制备方法与应用 |
| CN117120071A (zh) | 2020-12-18 | 2023-11-24 | 乌得勒支大学控股有限公司 | 刺激先天免疫记忆的cath2衍生物 |
| BR112023015724A2 (pt) | 2021-02-05 | 2023-11-07 | Univ Utrecht Holding Bv | Cath2 e derivados para inibir streptococcus suis |
| US20240342242A1 (en) * | 2021-08-05 | 2024-10-17 | Zoetis Services Llc | Compositions and methods for treating mastitis |
| WO2023114564A1 (en) * | 2021-12-15 | 2023-06-22 | Zoetis Services Llc | Compositions and methods for activating innate immunity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007064903A1 (en) | 2005-12-02 | 2007-06-07 | The Board Of Regents For Oklahoma State University | Fowlicidins and methods of their use |
-
2010
- 2010-02-12 HU HUE10704016A patent/HUE031681T2/en unknown
- 2010-02-12 WO PCT/NL2010/050068 patent/WO2010093245A1/en active Application Filing
- 2010-02-12 TR TR2019/01717T patent/TR201901717T4/tr unknown
- 2010-02-12 PL PL10704016T patent/PL2396345T3/pl unknown
- 2010-02-12 PL PL16197733T patent/PL3150627T3/pl unknown
- 2010-02-12 US US13/201,070 patent/US9006174B2/en active Active
- 2010-02-12 ES ES10704016.4T patent/ES2613266T3/es active Active
- 2010-02-12 SI SI201031853T patent/SI3150627T1/sl unknown
- 2010-02-12 ES ES16197733T patent/ES2710785T3/es active Active
- 2010-02-12 DK DK16197733.5T patent/DK3150627T3/en active
- 2010-02-12 EP EP16197733.5A patent/EP3150627B1/en active Active
- 2010-02-12 PT PT16197733T patent/PT3150627T/pt unknown
- 2010-02-12 HU HUE16197733A patent/HUE042310T2/hu unknown
- 2010-02-12 PT PT107040164T patent/PT2396345T/pt unknown
- 2010-02-12 EP EP10704016.4A patent/EP2396345B1/en active Active
- 2010-02-12 DK DK10704016.4T patent/DK2396345T3/en active
-
2015
- 2015-03-26 US US14/669,228 patent/US10301363B2/en active Active
-
2019
- 2019-02-11 HR HRP20190262TT patent/HRP20190262T1/hr unknown
- 2019-04-10 US US16/380,790 patent/US11186619B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20150197547A1 (en) | 2015-07-16 |
| US9006174B2 (en) | 2015-04-14 |
| WO2010093245A1 (en) | 2010-08-19 |
| PL2396345T3 (pl) | 2017-06-30 |
| DK2396345T3 (en) | 2017-02-13 |
| US10301363B2 (en) | 2019-05-28 |
| ES2710785T3 (es) | 2019-04-26 |
| PT3150627T (pt) | 2019-02-18 |
| PT2396345T (pt) | 2017-02-10 |
| DK3150627T3 (en) | 2019-03-11 |
| US20190233483A1 (en) | 2019-08-01 |
| EP2396345B1 (en) | 2016-11-09 |
| ES2613266T3 (es) | 2017-05-23 |
| HUE042310T2 (hu) | 2019-06-28 |
| SI3150627T1 (sl) | 2019-03-29 |
| EP2396345A1 (en) | 2011-12-21 |
| HRP20190262T1 (hr) | 2019-04-05 |
| EP3150627A1 (en) | 2017-04-05 |
| PL3150627T3 (pl) | 2019-05-31 |
| EP3150627B1 (en) | 2018-11-21 |
| US20120093844A1 (en) | 2012-04-19 |
| HUE031681T2 (en) | 2017-08-28 |
| US11186619B2 (en) | 2021-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201901717T4 (tr) | CMAP27 ye dayalı antimikrobiyal peptidler. | |
| EA201390254A1 (ru) | Модифицированные полипептиды релаксина и их применение | |
| EA201171494A1 (ru) | Миметики белка smac | |
| TR201809514T4 (tr) | Uzun süre etkili insülin formülasyonları. | |
| DK2190473T3 (da) | Peptid med reduceret dimerdannelse | |
| UA118167C2 (uk) | Пептид та його застосування | |
| MX2012007161A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
| MX2012007098A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
| JO3416B1 (ar) | تركيبات مضادة للبكتيريا وطرق استخدامها | |
| WO2010034718A8 (fr) | Proteines recombinantes a activite hemostatique capables d'induire l'agregation plaquettaire | |
| CL2012002879A1 (es) | Proteína recombinante robo1-fc que comprende el dominio extracelular de la isoforma b de la proteína robo1 o una parte de este dominio, un conector y un dominio fc de una inmunoglobulina; molécula de ácido nucleico que la codifica; composición farmacéutica que la comprende; y su uso como herramienta de diagnóstico para detectar la sobreexpresión de una molécula de la familia slit en un paciente. | |
| BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| DK2657333T3 (da) | Porcint circovirus type 2, immunsammensætning indeholdende samme, assaykit og anvendelse deraf | |
| TR201907828T4 (tr) | Geni̇ş spektrumlu bi̇r anti̇-mi̇krobi̇yel ajan | |
| BR112012030482A2 (pt) | tratamento de diabetes tipo 2 | |
| EA201201406A1 (ru) | Фунгицидные смеси ii, содержащие хиназолины | |
| TR201909522T4 (tr) | Anti-tümör aktivitesine sahip bir nonapeptit. | |
| TR201910526T4 (tr) | N-sübstitüe sülfoniloksibenzilaminler ve ilgili bileşiklerin kozmetik kullanımı. | |
| EA201390799A1 (ru) | Триазолопиридины | |
| BR112013003530A2 (pt) | ''produto farmacêutico, kit, uso e preparações'' | |
| MX2009013682A (es) | Enlazador de fmoc polimerico hidrolizable. | |
| CL2012003322A1 (es) | Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer. | |
| EA201290792A1 (ru) | Пептиды для вакцины против аллергии на березу | |
| MX2011008179A (es) | Peptidos para vacuna. | |
| WO2010052243A3 (en) | Neurotensin-derived branched peptides and uses thereof |